Diagnosed with a rare childhood cancer discovered just in time, surgery, proton therapy and chemotherapy saved two-year-old ...

The Oral Medicine Services team at Fred Hutch Cancer Center addresses the complex oral health needs of patients undergoing ...

When offered the opportunity to participate in clinical trials, patients with breast cancer across racial and ethnic groups ...

During the early days of research on bone marrow transplants, the procedure was difficult for patients to endure and had a ...

But the surge in Chinese pharma is still ringing alarm bells. “China’s rise in biotech is a threat to the United States,” ...

Dr. Hans-Peter Kiem is deputy director of the Translational Science and Therapeutics division at Fred Hutch. His specialty is gene therapy and stem cell engineering, specifically for blood cell ...

Valarie Traynham shares what survivorship means to her, and how the definition has evolved after her diagnosis, during National Cancer Survivors Month.

Frederick R. Appelbaum, MD, recognized for advancing marrow transplantation, talks about the impact of canine research on ...

May 29—Fred Hutchinson Cancer Center has agreed to pay about $11.5 million to patients after a 2023 cyberattack put their personal data at risk. Hackers targeted parts of Fred Hutch's clinical ...

New research shows a single dose leads to 'robust' reductions in depression and anxiety up to 2 years afterward.

The SEQUOIA arm D study demonstrates promising outcomes for treatment-naive patients with CLL, including high-risk patients.